AWS HealthOmics is a HIPAA-eligible service that fully manages the compute, storage, and workflow engine infrastructure required to run bioinformatics analyses at scale for clinical diagnostics, drug discovery, and agricultural research. Improper limitation of a pathname to a restricted directory in the linting tools of the AWS HealthOmics MCP Server (aws-healthomics-mcp-server) before version 0.0.36 might allow an actor who can influence the MCP agent to write an actor-controlled content to arbitrary locations outside the intended workflow bundle directory, via directory traversal sequences in the workflow_files input. To remediate this issue, users should upgrade to version 0.0.36 or later.
Fix
Nothing published yet: no patch, vendor advisory or mitigation reference on NVD, no vendor advisory in the News for this CVE, not in CISA's KEV, no fixed package version. BaselineWatch does not guess at one.
Change history 1
- First seenCVSS 6.8NVD modified 2026-10-24 20:10
Affected (CPE criteria) 0
NVD has not attached CPE configurations yet.